Skip to main content
. 2011 Mar 15;36(1):131–137. doi: 10.1007/s00264-011-1230-x

Table 1.

Distribution of patient, tumour, and treatment characteristics by margin of resection

Factor Patient group Positive margin Close margin Wide margin P value
(N = 7) n (%) (N = 12) n (%) (N = 28) n (%)
Age < 22 4 (17.4) 3 (13) 16 (69.6) 0.158
≥ 22 3 (12.5) 9 (37.5) 12 (50)
Gender Male 3 (10.7) 7 (25) 18 (64.3) 0.583
Female 4 (21.1) 5 (26.3) 10 (52.6)
Tumour site Extremities 5 (12.2) 12 (29.3) 24 (58.5) 0.184
Trunk 2 (33.3) 0 (0) 4 (66.7)
MSTS stage IIB 6 (15) 9 (22.5) 25 (62.5) 0.508
IIIB 1 (14.3) 3 (42.9) 3 (42.9)
Surgery type Amputation 2 (33.3) 0 (0) 4 (66.7) 0.184
Resection 5 (12.2) 12 (29.3) 24 (58.5)
Pathological type Osteoblastic 4 (10.5) 10 (26.3) 24 (63.2) 0.221
Other type 3 (33.3) 2 (22.2) 4 (44.4)
Preop chemo CDDP, ADRIA, MTX 4 (12.9) 8 (25.8) 19 (61.3) 0.865
Other regimens 3 (18.8) 4 (25) 9 (56.3)
Size (8.2 cm cut-off) <8.2 cm 1 (4.5) 7 (31.8) 14 (63.6) 0.145
≥8.2 cm 6 (25) 5 (20.8) 13 (54.2)
Histological response Good (≥90%) 2 (16.7) 1 (8.3) 9 (75) 0.280
Poor (<90%) 5 (14.3) 11 (31.4) 19 (54.3)

Preop chemo preoperative chemotherapy regimens, CDDP cisplatin, ADRIA adriamycin, MTX methotrexate